Skip to main content

News

January 20, 2021
Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire…
November 16, 2020
medQ Inc, a leading provider of automated imaging workflow solutions, has signed a strategic partnership agreement with Shina Systems Ltd., a market leader in imaging applications and AI open platform PACS solutions.
November 16, 2020
Cardiovascular Institute of the South is the only facility in Louisiana that has been awarded Gold Status by the American Heart Association and the American Medical Association for its commitment to keeping patient blood pressure rates under control…
November 11, 2020
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses…
November 11, 2020
AstraZeneca’s BRILINTA® (ticagrelor) has been approved in the U.S. to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-…
November 09, 2020
Twelve-Month Results Presented in Late-Breaking Trials Session at Vascular Interventional Advances (VIVA) Conference PARIS – November 9, 2020 — LimFlow SA, the pioneer in the development of minimally-invasive technology for the treatment of chronic…
November 09, 2020
hockwave Medical, Inc., offering Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, reported today that investigators unveiled data from the Disrupt PAD III study, which showed IVL to be superior to percutaneous…
November 09, 2020
Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrollment of the first patient in the SirPAD (Sirolimus in Peripheral Artery Disease) trial.
November 08, 2020
Meta-analysis of two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard…
November 06, 2020
AstraZeneca’s BRILINTA® (ticagrelor) has been approved in the U.S. to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-…
November 04, 2020
Medtronic plc announced the planned acquisition of Avenu Medical, a privately held medical device company based in San Juan Capistrano, Calif. focused on the endovascular (minimally invasive) creation of arteriovenous (AV) fistulae for patients with…
Back to Top